Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

NCT03876457 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT03876457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03876457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Not applicable
Overall status
Completed
Start date
October 11, 2019
Completion date
November 16, 2023
Enrollment
352 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke